ÂÜÀòÂÒÂ×

Philip Kantoff is currently the Co-Founder and Chief Executive Officer of Convergent Therapeutics, Inc., a position held since July 2021. Throughout their esteemed career, Philip has served as the Jerome and Nancy Kohlberg Professor Emeritus at Harvard Medical School since November 2015, while also contributing as a board member for the Prostate Cancer Foundation, ESSA Pharma, and Context Therapeutics. Previously, Philip held the role of Chairman of Medicine at Memorial Sloan Kettering Cancer Center from November 2015 to June 2021 and was the Division Head for Solid Tumor Oncology at Dana-Farber Cancer Institute from January 1991 to November 2015. Philip Kantoff earned a Doctor of Medicine (MD) degree in Medical Oncology from The Warren Alpert Medical School of Brown University.